CPI recognised in global IChemE Awards | CPI

CPI recognised in global IChemE Awards

The Centre for Process Innovation (CPI) has been shortlisted for two IChemE awards for the design, engineering and installation of the recently opened C1 gas fermentation laboratory at CPI and as part of a joint collaboration with AstraZeneca, Perceptive Engineering Limited and The University of Strathclyde in the development of novel continuous processing reactor capability and modelling techniques for the production of high value pharmaceuticals.

The IChemE Global Awards, in association with Aramco, celebrate excellence, innovation and achievement in the chemical, process and biochemical industries.

The C1 gas entry has been shortlisted in the category Research Project of the year award, this award is one of four new awards to be added to the list this year. The development laboratory is a recently completed open access facility designed to allow fermentation process development at 1 to 10L scales utilising C1 gases and hydrogen as feedstock’s as well as more traditional carbohydrate growth substrates. Equipped with a sophisticated array of gas monitoring, detection and control equipment, the facility allows safe operation with a range of gases and gas mixtures.

The winners of the global awards will be announced on 5 November 2015 at the Hilton Birmingham Metropole, UK. The ceremony in Birmingham is just one of several international events organised by IChemE to celebrate the achievements of the chemical engineering profession. Other events include the IChemE Singapore Awards (22 October 2015) and the IChemE Malaysia Awards (26 October 2015).

Steph McGovern will be hosting the awards and will announce the winners from 16 awards categories including Research Project of the Year, which will be selected from nearly 500 entries received worldwide.

CPI has also been recognised within the same award category as part of a joint collaboration with AstraZeneca, Perceptive Engineering Limited and The University of Strathclyde in the development of novel continuous processing reactor capability and modelling techniques for the production of high value pharmaceuticals. The new reactor technologies developed by the UK based consortium will enable pharmaceutical products that have traditionally been made in batches to be produced in a continuous manner. The developments have the potential to transform many formulating sectors by delivering excellent consistency results in product formulation alongside significant reductions in manufacturing costs and energy usage.